| Authors: |
Morris MJ; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA. Electronic address: morrism@mskcc.org., Mota JM; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Lacuna K; Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Hilden P; Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Gleave M; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada., Carducci MA; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA., Saad F; Division of Urology, University of Montreal Hospital Center (CHUM), Montreal, QC, Canada., Cohn ED; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Filipenko J; Prostate Cancer Clinical Trials Consortium, New York, NY, USA., Heller G; Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Shore N; Department of Urology, Carolina Urologic Research Center, Myrtle Beach, SC, USA., Armstrong AJ; Divisions of Medical Oncology and Urology, Departments of Medicine and Surgery at the Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University School of Medicine, Durham, NC, USA., Scher HI; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA. |
